Testing Build

CPD outcomes

Educational Activities (EA)

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

These are activities that use your work data to ensure quality results.

EA

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP

These are activities that require reflection on feedback about your work.

MO

These are activities that use your work data to ensure quality results.

Current Status

Not Enrolled

Price

Free

Get Started

Topic Summary

Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms. Whilst MHT is the most effective treatment for these symptoms, many women cannot, or choose not to take MHT.

Learning Objectives

  • Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms. Whilst MHT is the most effective treatment for these symptoms, many women cannot, or choose not to take MHT.
  • Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms. Whilst MHT is the most effective treatment for these symptoms, many women cannot, or choose not to take MHT.
  • Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms. Whilst MHT is the most effective treatment for these symptoms, many women cannot, or choose not to take MHT.

About the Expert

Prof Paul Griffin, Infectious Disease Expert

Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms. Whilst MHT is the most effective treatment for these symptoms, many women cannot, or choose not to take MHT.

CPD Information

Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms. Whilst MHT is the most effective treatment for these symptoms, many women cannot, or choose not to take MHT.

John Doe

John Doe

Software Engineer


dd

John Doe

John Doe

Software Engineer


ff

John Doe

John Doe

Software Engineer


hh

John Doe

John Doe

Software Engineer


ss

John Doe

John Doe

Software Engineer


aa

  • Andrew Vakulin, circle

    John Doe, prof

    Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms.

  • Yee, Brendon 2_Circle

    Peter Smith

    Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms.

  • King-Rosie_Circle-200x200-1

    Jane Doe

    Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms.

  • Srivastava, Piyush_circle

    Greg Amiss

    Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms.

  • Davis-Susan_circle

    Sarah Fletcher

    Menopausal vasomotor symptoms affect approximately 80% of women, of whom 1 in 3 experience moderate to severe symptoms.

Module Content

Introduction
Video Presentation
Quiz 1 Activity
Lesson Content
Micro Audit
Resources
Summary and Certificate

Recent Articles

Share this